Vivos Inc. (OTCMKTS:RDGL) Short Interest Update

Vivos Inc. (OTCMKTS:RDGL) was the target of a significant decline in short interest in the month of March. As of March 15th, there was short interest totalling 25,800 shares, a decline of 61.5% from the February 29th total of 67,000 shares. Based on an average daily volume of 1,240,000 shares, the short-interest ratio is presently 0.0 days.

Vivos Stock Performance

RDGL stock remained flat at $0.07 during midday trading on Thursday. The company’s stock had a trading volume of 218,239 shares, compared to its average volume of 554,130. The stock’s 50 day moving average is $0.06 and its two-hundred day moving average is $0.06. Vivos has a 52-week low of $0.04 and a 52-week high of $0.12.

Vivos Company Profile

Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States and internationally. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals.